Patents by Inventor Matthew Surman

Matthew Surman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230377877
    Abstract: Methods and related systems of processing a substrate. Described methods comprise executing a plurality of deposition cycles to form a doped hafnium zirconium oxide layer on the substrate.
    Type: Application
    Filed: May 18, 2023
    Publication date: November 23, 2023
    Inventors: Alessandra Leonhardt, Matthew Surman, Perttu Sippola, Ranjith Karuparambil Ramachandran, Charles Dezelah, Michael Givens, Andrea Illiberi, Tatiana Ivanova, Leo Lukose, Lorenzo Bottiglieri, Suvidyakumar Vinod Homkar, Vivek Koladi Mootheri
  • Publication number: 20230227452
    Abstract: The invention can provide compounds, analogs of blebbistatin, effective and selective inhibitors of nonmuscle myosin II relative to cardiac myosin II.
    Type: Application
    Filed: February 15, 2023
    Publication date: July 20, 2023
    Applicant: The University of Florida Research Foundation, Inc.
    Inventors: Courtney Anne MILLER, Patrick Robert GRIFFIN, Theodore Mark KAMENECKA, Gavin Rumbaugh, Matthew Surman, Steve Young, Steven Duddy, Laszlo Radnai
  • Patent number: 11649234
    Abstract: The invention can provide compounds, analogs of blebbistatin, effective and selective inhibitors of nonmuscle myosin II relative to cardiac myosin II.
    Type: Grant
    Filed: June 13, 2019
    Date of Patent: May 16, 2023
    Assignee: THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Courtney Miller, Patrick R. Griffin, Theodore Mark Kamenecka, Gavin Rumbaugh, Matthew Surman, Steve Young, Steven Duddy, Laszlo Radnai
  • Publication number: 20210317117
    Abstract: The invention can provide compounds, analogs of blebbistatin, effective and selective inhibitors of nonmuscle myosin II relative to cardiac myosin II.
    Type: Application
    Filed: June 13, 2019
    Publication date: October 14, 2021
    Inventors: Courtney Miller, Patrick R. Griffin, Theodore Mark Kamenecka, Gavin Rumbaugh, Matthew Surman, Steve Young, Steven Duddy, Laszlo Radnai
  • Patent number: 11020386
    Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: June 1, 2021
    Assignees: ALBANY MOLECULAR RESEARCH, INC., 3ST RESEARCH LLC
    Inventors: Matthew Surman, Kathryn Golden, Paolo Pasetto, Xiaomin Jin, Xiaowu Jiang, Fatoumata Camara, John K. Thottathil
  • Patent number: 10695342
    Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: June 30, 2020
    Assignees: ALBANY MOLECULAR RESEARCH, INC., 3ST RESEARCH LLC
    Inventors: Matthew Surman, John K. Thottathil, Kathryn Golden, Paolo Pasetto, Xiaomin Jin, Xiaowu Jiang, Fatoumata Camara
  • Publication number: 20170157116
    Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.
    Type: Application
    Filed: February 13, 2017
    Publication date: June 8, 2017
    Inventors: Matthew Surman, John K. Thottathil, Kathryn Golden, Paolo Pasetto, Xiaomin Jin, Xiaowu Jiang, Fatoumata Camara
  • Publication number: 20170151232
    Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.
    Type: Application
    Filed: February 13, 2017
    Publication date: June 1, 2017
    Inventors: Matthew Surman, Kathryn Golden, Paolo Pasetto, Xiaomin Jin, Xiaowu Jiang, Fatoumata Camara, John K. Thottathil
  • Publication number: 20160326182
    Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.
    Type: Application
    Filed: April 27, 2016
    Publication date: November 10, 2016
    Inventors: James Peltier, Matthew Surman, Kathryn Golden, Paolo Pasetto, Xiaomin Jin, Fatoumata Camara, Xiaowu Jiang
  • Publication number: 20060183908
    Abstract: In part, the present invention is directed to antibacterial compounds of formula (I) wherein A is a bicyclic heteroaryl ring or a tricyclic ring and R2 is an heterocyclic residue; L is a bond, or L is alkyl, alkenyl or cycloalkyl.
    Type: Application
    Filed: December 5, 2003
    Publication date: August 17, 2006
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Judd Berman, Peter Sampson, Heinz Pauls, Jailall Ramnauth, David Douglas, Matthew Surman, Dejian Xie, Helene Decornez